BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8063815)

  • 1. Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase.
    VanderKuur JA; Wang X; Zhang L; Campbell GS; Allevato G; Billestrup N; Norstedt G; Carter-Su C
    J Biol Chem; 1994 Aug; 269(34):21709-17. PubMed ID: 8063815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2.
    VanderKuur J; Allevato G; Billestrup N; Norstedt G; Carter-Su C
    J Biol Chem; 1995 Mar; 270(13):7587-93. PubMed ID: 7535773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor.
    VanderKuur JA; Wang X; Zhang L; Allevato G; Billestrup N; Carter-Su C
    J Biol Chem; 1995 Sep; 270(37):21738-44. PubMed ID: 7545168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
    Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
    Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription.
    Sotiropoulos A; Perrot-Applanat M; Dinerstein H; Pallier A; Postel-Vinay MC; Finidori J; Kelly PA
    Endocrinology; 1994 Oct; 135(4):1292-8. PubMed ID: 7925092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha.
    Stofega MR; Argetsinger LS; Wang H; Ullrich A; Carter-Su C
    J Biol Chem; 2000 Sep; 275(36):28222-9. PubMed ID: 10842184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors.
    Gong TW; Meyer DJ; Liao J; Hodge CL; Campbell GS; Wang X; Billestrup N; Carter-Su C; Schwartz J
    Endocrinology; 1998 Apr; 139(4):1863-71. PubMed ID: 9528972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1.
    Argetsinger LS; Hsu GW; Myers MG; Billestrup N; White MF; Carter-Su C
    J Biol Chem; 1995 Jun; 270(24):14685-92. PubMed ID: 7782332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
    Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase.
    Argetsinger LS; Campbell GS; Yang X; Witthuhn BA; Silvennoinen O; Ihle JN; Carter-Su C
    Cell; 1993 Jul; 74(2):237-44. PubMed ID: 8343952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.
    Stofega MR; Herrington J; Billestrup N; Carter-Su C
    Mol Endocrinol; 2000 Sep; 14(9):1338-50. PubMed ID: 10976913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct cytoplasmic domains of the growth hormone receptor are required for glucocorticoid- and phorbol ester-induced decreases in growth hormone (GH) binding. These domains are different from that reported for GH-induced receptor internalization.
    King AP; Tseng MJ; Logsdon CD; Billestrup N; Carter-Su C
    J Biol Chem; 1996 Jul; 271(30):18088-94. PubMed ID: 8663346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor.
    Frank SJ; Yi W; Zhao Y; Goldsmith JF; Gilliland G; Jiang J; Sakai I; Kraft AS
    J Biol Chem; 1995 Jun; 270(24):14776-85. PubMed ID: 7540178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling.
    He K; Wang X; Jiang J; Guan R; Bernstein KE; Sayeski PP; Frank SJ
    Mol Endocrinol; 2003 Nov; 17(11):2211-27. PubMed ID: 12920237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase.
    Frank SJ; Gilliland G; Kraft AS; Arnold CS
    Endocrinology; 1994 Nov; 135(5):2228-39. PubMed ID: 7956946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone.
    Carter-Su C; Rui L; Stofega MR
    Recent Prog Horm Res; 2000; 55():293-311. PubMed ID: 11036942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proline-rich region of the GH receptor is essential for JAK2 phosphorylation, activation of cell proliferation, and gene transcription.
    Dinerstein H; Lago F; Goujon L; Ferrag F; Esposito N; Finidori J; Kelly PA; Postel-Vinay MC
    Mol Endocrinol; 1995 Dec; 9(12):1701-7. PubMed ID: 8614406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation.
    Wang X; Darus CJ; Xu BC; Kopchick JJ
    Mol Endocrinol; 1996 Oct; 10(10):1249-60. PubMed ID: 9121492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.